Terns Pharmaceuticals Stock Investor Sentiment
| TERN Stock | USD 3.14 0.02 0.63% |
About 66% of Terns Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Terns Pharmaceuticals stock suggests that many investors are alarmed at this time. Terns Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Terns Pharmaceuticals. Many technical investors use Terns Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Comfort Level 34
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Terns Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Terns Pharmaceuticals.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Terns Historical Sentiment
Although Terns Pharmaceuticals' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Terns, such as negative comments on social media and news outlets, may cause fear in the market and push Terns Pharmaceuticals' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Terns.
Terns |
Terns Pharmaceuticals Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Terns Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Terns Pharmaceuticals Historical Investor Sentiment
Investor biases related to Terns Pharmaceuticals' public news can be used to forecast risks associated with an investment in Terns. The trend in average sentiment can be used to explain how an investor holding Terns can time the market purely based on public headlines and social activities around Terns Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Terns Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Terns Pharmaceuticals and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Terns Pharmaceuticals news discussions. The higher the estimate score, the more favorable the investor's outlook on Terns Pharmaceuticals.
Far too much social signal, news, headlines, and media speculation about Terns Pharmaceuticals that are available to investors today. That information is available publicly through Terns media outlets and privately through word of mouth or via Terns internal channels. However, regardless of the origin, that massive amount of Terns data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Terns Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Terns Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Terns Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Terns Pharmaceuticals alpha.
Terns Pharmaceuticals Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 8760 shares by Quigley Jill M. of Terns Pharmaceuticals at 5.7943 subject to Rule 16b-3 | 01/06/2025 |
2 | Acquisition by Fellows David A of 18650 shares of Terns Pharmaceuticals at 4.46 subject to Rule 16b-3 | 01/31/2025 |
3 | Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635 | 02/03/2025 |
4 | Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences ... | 02/05/2025 |
5 | We Think Terns Pharmaceuticals Can Afford To Drive Business Growth | 02/06/2025 |
6 | Insider Trading | 02/11/2025 |
7 | Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference | 02/25/2025 |
8 | Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635 | 02/26/2025 |
9 | Disposition of 103870 shares by Vivo Opportunity, Llc of Terns Pharmaceuticals at 6.2 subject to Rule 16b-3 | 03/14/2025 |
Check out Terns Pharmaceuticals Hype Analysis, Terns Pharmaceuticals Correlation and Terns Pharmaceuticals Performance. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Terns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Terns Pharmaceuticals is measured differently than its book value, which is the value of Terns that is recorded on the company's balance sheet. Investors also form their own opinion of Terns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Terns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Terns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Terns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Terns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.